Phase 2,3 trial data of India's first mRNA COVID vaccine submitted to DCGI

Pune-based Gennova Biopharmaceuticals, India's first mRNA COVID vaccine

Related Keywords

India ,Balram Bhargava ,Indian Council Of Medical Research ,Expert Committee ,Member Health Niti Aayog ,Google News ,Image Source ,Gennova Biopharmaceuticals ,Drugs Controller General ,Indian Council ,Medical Research ,Niti Aayog ,Subject Expert Committee ,Hyderabad Based Biological ,Receptor Binding Domain ,Precaution Dose ,Pune Based Gennova Biopharmaceuticals ,Ndias First Mrna Covid Vaccine ,